Table 3.
Diagnosis | Population | Medication | Dose | Duration |
---|---|---|---|---|
Paucibacillary leprosy | ||||
Adults | ||||
Rifampicin | 600 mg/month | 6 months | ||
Clofazimine | 300 mg/month + 50 mg/day | 6 months | ||
Dapsone | 100 mg/day | 6 months | ||
Children (10–14 years) | ||||
Rifampicin | 450 mg/month | 6 months | ||
Clofazimine | 150 mg/month + 50 mg/day | 6 months | ||
Dapsone | 50 mg/day | 6 months | ||
Children (<10 years old or <40 kg) | ||||
Rifampicin | 10 mg/kg/month | 6 months | ||
Clofazimine | 6 mg/kg/month + 1 mg/kg/day | 6 months | ||
Dapsone | 2 mg/kg/daily | 6 months | ||
Multibacillary leprosy | ||||
Adult | ||||
Rifampicin | 600 mg/month | 12 months | ||
Clofazimine | 300 mg/month + 50 mg/day | 12 months | ||
Dapsone | 100 mg/day | 12 months | ||
Children (10–14 years) | ||||
Rifampicin | 450 mg/month | 12 months | ||
Clofazimine | 150 mg/month + 50 mg/day | 12 months | ||
Dapsone | 50 mg/day | 12 months | ||
Children (<10 years old or <40 kg | ||||
Rifampicin | 10 mg/kg/month | 12 months | ||
Clofazimine | 6 mg/kg/month + 1 mg/kg/day | 12 months | ||
Dapsone | 2 mg/kg/daily | 12 months |